These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2253054)

  • 41. Altered topoisomerase II alpha in a drug-resistant small cell lung cancer cell line selected in VP-16.
    Mirski SE; Evans CD; Almquist KC; Slovak ML; Cole SP
    Cancer Res; 1993 Oct; 53(20):4866-73. PubMed ID: 8104687
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vitro multidrug resistance of P388 murine leukemia selected for resistance to diaziquone.
    Gutierrez PL; Wilder PJ; Biswal N
    Cancer Commun; 1989; 1(3):181-90. PubMed ID: 2576972
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A study of the mechanism of resistance to Adriamycin in vivo. Glutathione metabolism, P-glycoprotein expression, and drug transport.
    Lee FY; Sciandra J; Siemann DW
    Biochem Pharmacol; 1989 Nov; 38(21):3697-705. PubMed ID: 2574574
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Relationship of VP-16 to the classical multidrug resistance phenotype.
    Sehested M; Friche E; Jensen PB; Demant EJ
    Cancer Res; 1992 May; 52(10):2874-9. PubMed ID: 1581902
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Characterization of the mechanism of cross-resistance to vinca alkaloids and taxoids in the human J82 bladder tumor cell line].
    Debal V; Allam N; Morjani H; Millot JM; Gourdier B; Breillout F; Manfait M
    Bull Cancer; 1994 Oct; 81(10):891-3. PubMed ID: 7734773
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Resistance to the antimitotic drug estramustine is distinct from the multidrug resistant phenotype.
    Speicher LA; Sheridan VR; Godwin AK; Tew KD
    Br J Cancer; 1991 Aug; 64(2):267-73. PubMed ID: 1892755
    [TBL] [Abstract][Full Text] [Related]  

  • 47. P-glycoprotein expression and schedule dependence of adriamycin cytotoxicity in human colon carcinoma cell lines.
    Lai GM; Chen YN; Mickley LA; Fojo AT; Bates SE
    Int J Cancer; 1991 Nov; 49(5):696-703. PubMed ID: 1682280
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterization of an unusual mutant of human melanoma cells resistant to anticancer drugs that inhibit topoisomerase II.
    Campain JA; Padmanabhan R; Hwang J; Gottesman MM; Pastan I
    J Cell Physiol; 1993 May; 155(2):414-25. PubMed ID: 8097746
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Heterogeneity of chemosensitivity in six clonal cell lines derived from a spontaneous murine astrocytoma and its relationship to genotypic and phenotypic characteristics.
    Bradford R; Koppel H; Pilkington GJ; Thomas DG; Darling JL
    J Neurooncol; 1997 Sep; 34(3):247-61. PubMed ID: 9258817
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of differential drug uptake, efflux, and binding of etoposide in sensitive and resistant human tumor cell lines: implications for the mechanisms of drug resistance.
    Politi PM; Sinha BK
    Mol Pharmacol; 1989 Mar; 35(3):271-8. PubMed ID: 2564628
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reduced activity of topoisomerase II in an Adriamycin-resistant human stomach-adenocarcinoma cell line.
    Son YS; Suh JM; Ahn SH; Kim JC; Yi JY; Hur KC; Hong WS; Muller MT; Chung IK
    Cancer Chemother Pharmacol; 1998; 41(5):353-60. PubMed ID: 9523730
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mitomycin C cross-resistance induced by adriamycin in human ovarian cancer cells in vitro.
    Mizuno K; Furuhashi Y; Maeda O; Iwata M; Misawa T; Kawai M; Kano T; Tomoda Y
    Cancer Chemother Pharmacol; 1990; 26(5):333-9. PubMed ID: 1976451
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Drug-related chromosomal changes in chemoresistant human ovarian carcinoma cells.
    Teyssier JR; Bénard J; Ferre D; Da Silva J; Renaud L
    Cancer Genet Cytogenet; 1989 May; 39(1):35-43. PubMed ID: 2731146
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Development of an orthotopic SCID mouse-human tumor xenograft model displaying the multidrug-resistant phenotype.
    Bellamy WT; Mendibles P; Bontje P; Thompson F; Richter L; Weinstein RS; Grogan TM
    Cancer Chemother Pharmacol; 1996; 37(4):305-16. PubMed ID: 8548875
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The protein kinase C inhibitor CGP 41251, a staurosporine derivative with antitumor activity, reverses multidrug resistance.
    Utz I; Hofer S; Regenass U; Hilbe W; Thaler J; Grunicke H; Hofmann J
    Int J Cancer; 1994 Apr; 57(1):104-10. PubMed ID: 7908658
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [In vitro characterization of S9788, a new modulator of multidrug resistance].
    Pérez V; Pierré A; Léonce S; Anstett M; Prost JF; Atassi G
    Bull Cancer; 1993 Apr; 80(4):310-25. PubMed ID: 8173185
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characterization of newly established human myeloid leukemia cell line (KF-19) and its drug resistant sublines.
    Fukuda T; Kamishima T; Kakihara T; Ohnishi Y; Suzuki T
    Leuk Res; 1996; 20(11-12):931-9. PubMed ID: 9009251
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Potentiation of some anticancer agents by dipyridamole against drug-sensitive and drug-resistant cancer cell lines.
    Asoh K; Saburi Y; Sato S; Nogae I; Kohno K; Kuwano M
    Jpn J Cancer Res; 1989 May; 80(5):475-81. PubMed ID: 2568984
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differential cytotoxicity of 19 anticancer agents in wild type and etoposide resistant small cell lung cancer cell lines.
    Jensen PB; Christensen IJ; Sehested M; Hansen HH; Vindeløv L
    Br J Cancer; 1993 Feb; 67(2):311-20. PubMed ID: 8094293
    [TBL] [Abstract][Full Text] [Related]  

  • 60. P388 leukaemia cells resistant to the anthracycline menogaril lack multidrug resistant phenotype.
    Badiner GJ; Moy BC; Smith KS; Tarpley WG; Groppi VE; Bhuyan BK
    Br J Cancer; 1990 Sep; 62(3):378-84. PubMed ID: 2145026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.